Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Late-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingLate-stage development of AS-241, an UNC13A Targeting Antisense Oligonucleotide treatment for Amyotrophic Lateral Sclerosis, for IND-enabling studies

Microglia replacement therapy for CSF1R-related Leukoencephalopathy

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingMicroglia replacement therapy for CSF1R-related Leukoencephalopathy

CRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingCRISPR/Cas9-mediated gene editing of Hematopoietic stem and progenitor cells for Friedreich’s ataxia

Development of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingDevelopment of an AAV Epigenetic Gene Therapy for Intractable Chronic Pain Disorders

Dissecting cell-specific genetic and molecular drivers of amyotrophic lateral sclerosis for therapeutic insights

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingDissecting cell-specific genetic and molecular drivers of amyotrophic lateral sclerosis for therapeutic insights

Transplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingTransplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders

Advancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingAdvancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders

Reversing age-dependent neurodegeneration by elimination of RNA pollution

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingReversing age-dependent neurodegeneration by elimination of RNA pollution

Tracing the metabolic basis of neurological disorders

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Continue ReadingTracing the metabolic basis of neurological disorders

Modeling the genetic basis of psychopathology in schizophrenia and autism

  • Post author:
  • Post published:May 25, 2026
  • Post category:

Research Objective We propose to apply scalable platforms for the characterization of CNVs and genes coupled with detailed characterizations of neurodevelopment of the 4 major CNV loci in model systems…

Continue ReadingModeling the genetic basis of psychopathology in schizophrenia and autism
  • Go to the previous page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 36
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us